# Primary Peritoneal Low-Grade Serous Carcinoma in a 16-Year-Old Female: A Case Report

**Authors:** Yuang An, Yijian Fan, Yu Xia

PMC · DOI: 10.3390/jcm15062343 · Journal of Clinical Medicine · 2026-03-19

## TL;DR

A 16-year-old girl was diagnosed with a rare form of peritoneal cancer, highlighting the need to consider this condition in young patients with pelvic masses.

## Contribution

This case report presents an extremely rare instance of primary peritoneal low-grade serous carcinoma in an adolescent female.

## Key findings

- The patient had a pelvic mass with histopathology confirming low-grade serous carcinoma.
- The tumor involved the anterior rectal wall, bilateral adnexal surfaces, and peritoneum.
- The patient underwent surgery and chemotherapy with no recurrence observed during follow-up.

## Abstract

Background: Primary peritoneal carcinoma (PPC) is an uncommon malignancy typically diagnosed in postmenopausal women, accounting for less than 1% of all gynecologic cancers. Its occurrence in adolescents is extremely rare. We present a case of a 16-year-old female with low-grade serous carcinoma (LGSC) arising from the anterior rectal peritoneum, highlighting diagnostic challenges and therapeutic considerations. Case Presentation: A 16-year-old girl presented with a 7-day history of lower abdominal pain. Ultrasound revealed an 8 cm mixed cystic–solid pelvic mass anterior to the rectum. Laboratory tests showed elevated CA-125 (106 U/mL). Exploratory laparotomy demonstrated an 8 cm solid mass attached to the anterior rectal wall, extending into the right mesorectum with peritoneal nodules at the bladder reflection. The uterus and adnexa appeared grossly normal. Frozen section analysis revealed adenocarcinoma with psammoma body formation. Histopathology and immunohistochemistry confirmed low-grade serous carcinoma: PAX8(+), WT1(+), CK7(+), ER(60%), PR(40%), CK20(–), and P53 wild-type. Peritoneal washings contained rare malignant cells. Postoperatively, the patient underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, and omentectomy. Final pathology confirmed low-grade serous carcinoma involving the anterior rectal wall, bilateral adnexal surfaces, and peritoneum. She completed six cycles of adjuvant chemotherapy (paclitaxel + carboplatin, TC regimen). No recurrence was observed during follow-up. Conclusions: This case underscores the importance of considering PPC in the differential diagnosis of pelvic masses in young females, even when the ovaries appear normal.

## Linked entities

- **Proteins:** PAX8 (paired box 8), WT1 (WT1 transcription factor), KRT7 (keratin 7), EREG (epiregulin), PGR (progesterone receptor), KRT20 (keratin 20), TP53 (tumor protein p53)
- **Chemicals:** paclitaxel (PubChem CID 36314), carboplatin (PubChem CID 426756)
- **Diseases:** primary peritoneal carcinoma (MONDO:0002113)

## Full-text entities

- **Genes:** EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, WT1 (WT1 transcription factor) [NCBI Gene 7490] {aka AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, PAX8 (paired box 8) [NCBI Gene 7849] {aka PAX-8}, MUC16 (mucin 16, cell surface associated) [NCBI Gene 94025] {aka CA125}
- **Diseases:** gynecologic cancers (MESH:D009369), PPC (MESH:D010534), pelvic masses (MESH:C536030), LGSC (MESH:D015451), adenocarcinoma (MESH:D000230), abdominal pain (MESH:D015746)
- **Chemicals:** TC (MESH:D013667), carboplatin (MESH:D016190), paclitaxel (MESH:D017239)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026238/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13026238/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026238/full.md

---
Source: https://tomesphere.com/paper/PMC13026238